Skip to main content

Accelerating Regenerative Medicine

Follow RegMed XB on LinkedIn
  • Upcoming events

    Annual2025

    Annual Conference 2026

    Be part of the 4th RegMed XB Annual Conference: Collaborate to Regenerate. Get inspired and expand your network within the regenerative medicine field.

    read more
  • Expertise

    Business Development & Valorization

    Accelerating Innovation in Regenerative Medicine

    read more

    Research Excellence: Moonshots

    Push the boundaries of research excellence

    read more

    Infrastructure: RegMed XB's Pilot Factory

    A seamless pathway for innovators to accelerate, de-risk, and scale regenerative therapies

    read more

    Public-Private Entrepreneurship

    Building ecosystems through collaboration

    read more

    Seed Capital

    Secure early-stage funding

    read more
  • Latest news

    Renal_replacement_therapy_in_Regenerative_Medicine

    Renal replacement therapy in Regenerative Medicine

    Thomas Geuens, Vanessa LaPointe and Clemens van Blitterswijk from MERLN Institute of Maastricht University have published the paper “Overcoming kidney organoid challenges for regenerative medicine” discussing the recent advances and remaining challenges for kidney organoids to become successful in regenerative medicine.

    read more
    An_ex_vivo_human_osteochondral_culture_model

    An ex vivo human osteochondral culture model

    Congratulations to Meike W.A. Kleuskens on the publication of her paper “An ex vivo human osteochondral culture model” in the Journal of Orthopaedic Research.

    read more
    News slider

    More advances in research on kidney organoids

    Congratulations to Cathelijne W. van den Berg, on the publication of her paper “In Vivo Assessment of Size-Selective Glomerular Sieving in Transplanted Human Induced Pluripotent Stem Cell–Derived Kidney Organoids” in JASN magazine. Cathelijne is one of the researchers at Leiden University Medical Center working in the Kidney Moonshot, whose main goal is the creation of a functioning bioengineered kidney.

    read more
  • Moonshots (research excellence)

    Cardiovascular Moonshot

    Regeneration of the human heart

    read more

    Diabetes Moonshot

    A proof-of-concept therapy for Type 1 Diabetes

    read more

    Kidney Moonshot

    The first subunit of a bio-engineered kidney

    read more

    Osteoarthritis Moonshot

    The road to a bio-artificial joint

    read more
  • Pilot Factory (infrastructure)

    The RegMed XB Pilot Factory is one of the largest international infrastructures for regenerative medicine. It brings together all the expertise and infrastructure needed to bring regenerative medicine to the market.

    Pilot Factory

  • RegMed XB's Ecosystem

    Health Foundations

    The following Dutch health foundations are involved in defining research objectives and provide guidance in the research we conduct to ensure we maintain focus on the patient.

    read more

    Academic Partners

    RegMed XB works together with (inter)national top-rated academic institutions and collaborates specifically and exclusively with researchers who contribute specific expertise to the Moonshot initiatives.

    read more

    Industrial Partners

    Partnering with companies offers access to their expertise in designing scalable and feasible products. Currently, we have strong partnerships with the following entities.

    read more

    Governmental Partners

    RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.

    read more

    Life Science & Health partners

    The following Life Science & Health (LSH) partners are collaborate with RegMed XB.

    read more